Published Technical Disclosure Archive

Synergistic Cardiac Arrhythmia Treatment Systems

Publication ID: 24-11857380_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Cardiac Arrhythmia Treatment Systems,” Published Technical Disclosure No. 24-11857380_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857380_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,380.

Summary of the Inventive Concept

The present inventive concept integrates artificial intelligence, blockchain, IoT, and nanomaterial technologies with cardiac arrhythmia treatment devices to create a more effective, secure, and personalized treatment system.

Background and Problem Solved

The original patent disclosed a cardiac arrhythmia treatment device with limitations in real-time monitoring, data security, and biocompatibility. The present inventive concept addresses these limitations by incorporating AI-powered algorithms for optimizing pacing therapy, blockchain technology for secure data sharing, IoT connectivity for real-time monitoring, and nanomaterial-based coatings for enhanced biocompatibility.

Detailed Description of the Inventive Concept

The inventive concept comprises a pulse generator, a lead for cardiac therapy with a distal end configured to transmit therapeutic electrical pulses from the pulse generator to a heart, and an AI-powered algorithm for optimizing pacing therapy based on real-time heart rhythm data. Additionally, the system may include blockchain technology to securely store and share patient data with healthcare providers, an IoT network for real-time monitoring and feedback, and a nanomaterial-based coating on the lead for enhanced biocompatibility and reduced inflammation.

Novelty and Inventive Step

The integration of AI, blockchain, IoT, and nanomaterial technologies with cardiac arrhythmia treatment devices is new and non-obvious, providing a synergistic combination that enhances the effectiveness, security, and personalization of cardiac arrhythmia treatment.

Alternative Embodiments and Variations

Alternative embodiments may include using machine learning algorithms to predict and prevent cardiac arrhythmias, incorporating wearable devices or mobile applications for patient engagement and monitoring, or utilizing other advanced materials for lead coatings.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the cardiac arrhythmia treatment market, which is expected to grow due to the increasing prevalence of cardiac arrhythmias and the need for more effective and personalized treatment options. The target industries include medical device manufacturers, healthcare providers, and patients with cardiac arrhythmias.

CPC Classifications

SectionClassGroup
A A61 A61B90/39
A A61 A61B90/02
A A61 A61N1/0504
A A61 A61N1/0563
A A61 A61N1/0587
A A61 A61N1/362
A A61 A61N1/3621
A A61 A61N1/36521
A A61 A61N1/36542
A A61 A61N1/36557
A A61 A61N1/3787
A A61 A61N1/37217
A A61 A61N1/37264
A A61 A61N1/3956
A A61 A61B2090/3966
A A61 A61B2090/3983
A A61 A61N1/059
A A61 A61N1/3752

Field of Art

Medical Device Technology - Cardiac Rhythm Management Systems, specifically implantable pacemakers and therapeutic electrical pulse delivery devices. Requires advanced understanding of electrical engineering, medical device design, biomedical signal processing, and minimally invasive cardiac intervention techniques.

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with advanced degree, 5-10 years experience in cardiac rhythm management technologies, familiar with electrical pulse generation, lead design, implantation techniques, and emerging medical technology integration strategies

Obviousness Rationale

A PHOSITA would recognize that integrating contemporary digital technologies like AI, blockchain, and IoT into existing cardiac rhythm management device architectures represents a predictable technological evolution. The fundamental cardiac therapy delivery mechanism remains consistent with the source patent, with the PTD primarily adding computational and data management layers to an established medical device framework. These technological enhancements represent incremental improvements using known interdisciplinary techniques that would be apparent to a skilled practitioner seeking to optimize medical device performance and patient outcomes.

Obvious Combinations & Variations

Source Patent Element
Cardiac therapy lead with electrical pulse transmission capability
PTD Variation
Adding nanomaterial-based biocompatible coating to reduce inflammation
Obviousness Reasoning
Material science improvements for medical implants are a routine design optimization, with predictable goals of reducing patient tissue response and improving long-term device performance
Source Patent Element
Pulse generator for cardiac electrical stimulation
PTD Variation
Incorporating AI algorithm for real-time therapy optimization
Obviousness Reasoning
Adaptive signal processing and machine learning are well-established techniques for improving medical device responsiveness, representing a known method of enhancing therapeutic effectiveness
Source Patent Element
Cardiac lead insertion method into intercostal space
PTD Variation
Adding blockchain-based secure patient data management
Obviousness Reasoning
Integrating digital security and data management protocols is a standard approach for modernizing medical device ecosystems, using well-understood information technology techniques
Source Patent Element
Cardiac rhythm management device
PTD Variation
IoT network integration for real-time monitoring and feedback
Obviousness Reasoning
Connecting medical devices to networked monitoring systems is a predictable technological progression, leveraging established telecommunications and sensor network technologies
35 U.S.C. § 103 Summary: Based on US Patent 11857380's foundational teachings of cardiac rhythm management device architecture, the present publication demonstrates that a person of ordinary skill in the art would find the disclosed technological variations obvious and predictable extensions of existing medical device design principles. The integration of AI, blockchain, IoT, and advanced materials represents incremental improvements using known interdisciplinary techniques, thereby rendering potential derivative claims obvious and non-patentable under standard obviousness analysis.

Original Patent Information

Patent NumberUS 11,857,380
TitleCardiac arrhythmia treatment devices and delivery
Assignee(s)AtaCor Medical, Inc.